HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yao Wang Selected Research

SY 21

11/2003Possible mechanisms underlying the protective effects of SY-21, an extract of a traditional Chinese herb, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yao Wang Research Topics

Disease

181Neoplasms (Cancer)
11/2022 - 01/2003
48Infections
08/2022 - 10/2008
43Inflammation (Inflammations)
05/2022 - 01/2003
31Neoplasm Metastasis (Metastasis)
04/2022 - 03/2003
27Breast Neoplasms (Breast Cancer)
10/2022 - 01/2005
25Type 2 Diabetes Mellitus (MODY)
06/2022 - 04/2008
19Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2011
16COVID-19
04/2022 - 01/2020
16Wounds and Injuries (Trauma)
01/2022 - 01/2003
15Stroke (Strokes)
07/2022 - 05/2008
15Coronary Artery Disease (Coronary Atherosclerosis)
03/2022 - 01/2012
15Myocardial Infarction
02/2022 - 11/2004
15Hypoxia (Hypoxemia)
01/2022 - 12/2011
15Insulin Resistance
01/2022 - 01/2015
14Body Weight (Weight, Body)
06/2022 - 04/2008
14Diabetes Mellitus
06/2022 - 11/2004
14Ischemic Stroke
04/2022 - 11/2009
14Obesity
01/2022 - 05/2008
14Heart Failure
01/2022 - 01/2015
14Lung Neoplasms (Lung Cancer)
12/2021 - 01/2010
13Carcinogenesis
01/2022 - 10/2013
13Hypertension (High Blood Pressure)
01/2022 - 05/2008
13Carcinoma (Carcinomatosis)
09/2020 - 01/2003
12Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2013
12Acute Liver Failure (Fulminant Hepatic Failure)
11/2021 - 01/2018
12Fibrosis (Cirrhosis)
01/2021 - 03/2013
11Cognitive Dysfunction
07/2022 - 01/2016
11Hepatocellular Carcinoma (Hepatoma)
03/2022 - 09/2016
11Atherosclerosis
01/2022 - 09/2011
10Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 10/2010
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2011
10Hyperglycemia
01/2020 - 05/2008
9Sepsis (Septicemia)
06/2022 - 11/2010
9Graves Ophthalmopathy
01/2022 - 03/2014
9Stomach Neoplasms (Stomach Cancer)
12/2020 - 04/2013
9Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 11/2011
9Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 12/2014
9Colonic Neoplasms (Colon Cancer)
01/2020 - 07/2002
8Pain (Aches)
10/2022 - 01/2017
8Hemorrhage
04/2022 - 12/2014
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2012
8Necrosis
01/2022 - 10/2011
8Fever (Fevers)
08/2020 - 01/2013
8Lymphatic Metastasis
01/2020 - 11/2007
7Pre-Eclampsia (Preeclampsia)
04/2022 - 11/2017
7Neuroinflammatory Diseases
04/2022 - 06/2018
7Virus Diseases (Viral Diseases)
04/2022 - 07/2006
7Hypertrophy
03/2022 - 06/2010
7Autoimmune Diseases (Autoimmune Disease)
02/2020 - 08/2013
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2017
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 11/2015
7Melanoma (Melanoma, Malignant)
10/2019 - 06/2007
6Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 10/2010

Drug/Important Bio-Agent (IBA)

80Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2003
43Pharmaceutical PreparationsIBA
01/2022 - 08/2010
38Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2013
36CytokinesIBA
11/2022 - 06/2007
35Glucose (Dextrose)FDA LinkGeneric
06/2022 - 11/2004
26Chimeric Antigen ReceptorsIBA
11/2022 - 12/2014
24Long Noncoding RNAIBA
04/2022 - 05/2016
22Biological ProductsIBA
01/2022 - 10/2010
19MicroRNAs (MicroRNA)IBA
01/2022 - 11/2011
17Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 05/2012
17LipidsIBA
01/2022 - 04/2008
13Messenger RNA (mRNA)IBA
06/2022 - 07/2005
13Antiviral Agents (Antivirals)IBA
04/2022 - 07/2006
13RNA (Ribonucleic Acid)IBA
01/2022 - 01/2013
12Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2016
12Peptides (Polypeptides)IBA
10/2021 - 01/2012
11Blood Glucose (Blood Sugar)IBA
06/2022 - 05/2008
11Insulin (Novolin)FDA Link
01/2022 - 04/2008
11AntibodiesIBA
01/2022 - 05/2008
11AntigensIBA
03/2020 - 01/2013
10Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2012
9LigandsIBA
11/2022 - 07/2005
9CateninsIBA
08/2021 - 03/2016
9AlbuminsIBA
02/2020 - 12/2012
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 07/2012
8InterferonsIBA
04/2022 - 01/2010
8teprotumumabIBA
01/2022 - 01/2019
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2008
8Retinaldehyde (Retinal)IBA
01/2022 - 02/2015
8Therapeutic UsesIBA
12/2021 - 01/2012
8Indicators and Reagents (Reagents)IBA
11/2021 - 02/2015
8Interleukin-2 (IL2)IBA
02/2014 - 06/2007
7LipopolysaccharidesIBA
06/2022 - 06/2018
7Neuroprotective AgentsIBA
04/2022 - 01/2012
7AntioxidantsIBA
02/2022 - 01/2013
7VaccinesIBA
01/2022 - 01/2018
7Peptide Hydrolases (Proteases)FDA Link
10/2021 - 01/2011
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 06/2007
7EnzymesIBA
11/2020 - 06/2004
7Urokinase Plasminogen Activator ReceptorsIBA
10/2014 - 07/2002
6Carbapenems (Carbapenem Antibiotics)IBA
08/2022 - 01/2017

Therapy/Procedure

107Therapeutics
06/2022 - 07/2005
31Drug Therapy (Chemotherapy)
04/2022 - 10/2010
20Immunotherapy
02/2022 - 01/2010
9Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 12/2014
9Aftercare (After-Treatment)
11/2021 - 01/2010
7Radiotherapy
12/2021 - 06/2007